Literature DB >> 22796252

High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?

Emil M deGoma, Daniel J Rader.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22796252     DOI： 10.1016/j.jacc.2012.03.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

Review 1.  Highlights of the year in JACC 2012.

Authors:  Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-01-22       Impact factor: 24.094

Review 2.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

3.  High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.

Authors:  Samia Mora; Robert J Glynn; Paul M Ridker
Journal:  Circulation       Date:  2013-09-03       Impact factor: 29.690

4.  High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Authors:  Amisha V Barochia; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Patricia Theard; Debbie M Figueroa; Xianglan Yao; Nargues A Weir; Maureen L Sampson; Mario Stylianou; David F Choy; Cecile T J Holweg; Alan T Remaley; Stewart J Levine
Journal:  J Lipid Res       Date:  2017-06-27       Impact factor: 5.922

5.  Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Authors:  Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

Review 6.  Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.

Authors:  Gianluca Bardini; Carlo M Rotella; Stefano Giannini
Journal:  Rev Diabet Stud       Date:  2012-11-15

7.  The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions.

Authors:  Mark A Sarzynski; Jeffrey Burton; Tuomo Rankinen; Steven N Blair; Timothy S Church; Jean-Pierre Després; James M Hagberg; Rian Landers-Ramos; Arthur S Leon; Catherine R Mikus; D C Rao; Richard L Seip; James S Skinner; Cris A Slentz; Paul D Thompson; Kenneth R Wilund; William E Kraus; Claude Bouchard
Journal:  Atherosclerosis       Date:  2015-10-17       Impact factor: 5.162

8.  Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Authors:  Subroto Acharjee; William E Boden; Pamela M Hartigan; Koon K Teo; David J Maron; Steven P Sedlis; William Kostuk; John A Spertus; Marcin Dada; Bernard R Chaitman; G B John Mancini; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2013-08-21       Impact factor: 24.094

9.  P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.

Authors:  Marine Goffinet; Claudine Tardy; Nadia Boubekeur; Guy Cholez; Alice Bluteau; Daniela C Oniciu; Narendra D Lalwani; Jean-Louis H Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

10.  CETP inhibitors and cardiovascular disease: Time to think again.

Authors:  Norman E Miller
Journal:  F1000Res       Date:  2014-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.